The C-19 epimers of 5β,19-epoxycucurbita-6,23(E),25(26)-triene-3β,19-diol (1) and 5β,19-epoxy-25-methoxycucurbita-6,23-diene-3β,19-diol (2) along with (19R, 23E)-5β,19-epoxy-19-methoxycucurbita-6,23,25-trien-3β-ol (3), (23E)-5β,19-epoxycucurbita-6,23-diene-3β,25-diol (4), ligballinol (5), charantin (6) and momordicoside K (7) were isolated from the green fruits of Momordica charantia. The (S)-epimers of 1 and 2 are the first reports in nature. The acetyl- and butyryl-cholinesterase inhibitory activities of the isolated compounds were evaluated, and 5 showed the highest activity of these compounds against butyrylcholinesterase (IC50 = 32.20 μM) with a reversible and non-competitive inhibition mode.
PornsuriyaP., PornsuriyaP., NumuenC. (2011) Phenotypic diversity and classification of Thai bitter melon (Momordica charantia L.) landraces from three provinces in central region of Thailand. Journal of Agricultural Technology, 7, 849–856.
2.
ChakravartyH.L. (1990) Cucurbits of India and their role in the development of vegetable crop. In Biology and utilization of cucurbitaceae.BatesD.M., RobinsonR.W., JeffreyC. (Ed). Cornell University Press, New York, 325–334.
3.
KusamranW.R., TepsuwanA., KupradinunP. (1998) Antimutagenic and anticarcinogenic potentials of some Thai vegetables. Mutation Research, 402, 247–258.
4.
LimtrakulP., KhantamatO., PinthaK. (2004) Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract. Cancer Chemotherapy and Pharmacology, 54, 525–530.
5.
KubolaJ., SiriamornpunS. (2008) Phenolic contents and antioxidant activities of bitter gourd (Momordica charantia L.) leaf, stem and fruit fraction extracts in vitro. Food Chemistry, 110, 881–890.
6.
HaqueM.E., AlamM.B., HossainM.S. (2011) The efficacy of cucurbitane type triterpenoids, glycosides and phenolic compounds isolated from Momordica charantia: A review. International Journal Pharmaceutical Science Research, 2, 1135–1146.
7.
NhiemN.X., KiemP.V., MinhC.V., BanN.K., CuongN.X., TungN.H., HaL.M., HaD.T., TaiB.H., QuangT.H., NgocT.M., KwonY.I., JangH.D., KimY.H. (2010) α-Glucosidase inhibition properties of cucurbitane-type triterpene glycosides from the fruits of Momordica charantia. Chemical and Pharmaceutical Bulletin, 58, 720–724.
8.
LiuC.H., YenM.H., TsangS.F., GanK.H., HsuH.Y., LinC.N. (2010) Antioxidant triterpenoids from the stems of Momordica charantia. Food Chemistry, 118, 751–756.
9.
RamanA., LauC. (1996) Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicine, 2, 349–362.
10.
JiratchariyakulW., WiwatC., VongsakulM., SomanabandhuA., LeelamanintW., FujiiI., SuwannarojN., EbizukaY. (2001) HIV inhibitor form Thai bitter gourd. Planta Medica, 67, 350–353.
11.
PitchakarnP., OgawaK., SuzukiS., TakahashiS., AsamotoM., ChewonarinT., LimtrakulP., ShiraiT. (2010) Momordica charantia leaf extract suppresses rat prostate cancer progression in vitro and in vivo. Cancer Science, 101, 2234–2240.
12.
PitchakarnP., SuzukiS., OgawaK., PompimonW., TakahashiS., AsamotoM., LimtrakulP., ShiraiT. (2011) Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by kuguacin J, a triterpenoid from Momordica charantia leaf. Cancer Letters, 306, 142–150.
PitchakarnP., SuzukiS., OgawaK., PompimonW., TakahashiS., AsamotoM., LimtrakulP., ShiraiT. (2012) Kuguacin J, a triterpeniod from Momordica charantia leaf, modulates the progression of androgen-independent human prostate cancer cell line, PC3. Food and Chemical Toxicology, 50, 840–847.
15.
SramekJ.J., ZarotskyV., CutlerN.R. (2002) Review of drug development and therapeutic role cholinesterase inhibitors in Alzheimer's disease. Drug Development Research, 56, 347–353.
ZhangY., CuiJ.M., PiaoH.R., ZhaoY.Q. (2009) Novel compounds in Momordica charantia. Chinese Traditional and Herb Drugs, 40, 509–512.
18.
MulhollandD.A., SewramV., OsborneR., PegelK.H., ConnollyJ.D. (1997) Cucurbitane triterpenoids from the leaves of Momordica foetida. Phytochemistry, 45, 391–395.
19.
ChangC.I., TsengH.I., LiaoY.W., YenC.H., ChenT.M., LinC.C., ChengH.L. (2011) In vivo and in vitro studies to identify the hypoglycaemic constituents of Momordica charantia wild variant WB24. Food Chemistry, 125, 521–528.
20.
KimuraY., AkihisaT., YuasaN., UkiyaM., SuzukiT., ToriyamaM., MotohashiS., TokudaH. (2005) Cucurbitane-type triterpenoids from the fruit of Momordica charantia. Journal of Natural Products, 68, 807–809.
21.
ChangC.I., ChenC.R., LiaoY.W., ChengH.L., ChenY.C., ChouC.H. (2006) Cucurbitane-type triterpenoids from Momordica charantia. Journal of Natural Products, 69, 1168–1171.
22.
KobayashiM., OhtaY. (1983) Induction of stress metabolite formation in suspension cultures of Vigna angularis.Phytochemistry, 22, 1257–1261.
23.
WangX.W., ZhangH.P., ChenF., WangX., WenW.Y. (2009) A new lignan from Gynostemma pentaphyllum. Chinese Chemical Letters, 20, 589–591.
24.
PitipanapongJ., ChitprasertS., GotoM., JiratchariyakulW., SasakiM., ShotiprukA. (2007) New approach for extraction of charantin from Momordica charantia with pressurized liquid extraction. Separation and Purification Technology, 52, 416–422.
25.
OkabeH., MiyaharaY., YamaushiT. (1982) Studies on the constituents of Momordica charantia L.: IV. Characterization of the new cucurbitacin glycosides of the immature fruits: Structures of the bitter glycosides, momordicosides K and L. Chemical and Pharmaceutical Bulletin, 30, 4334–4340.
26.
ItohK., IshigeA., HosoyaE. (1989) Cerebral function improvising drug containing a gomisin. Patent-PCT Int Appl-8908, 451–473.
KucukboyaciN., SenerB. (2010) Biological activities of lignans from Taxus baccata L. growing in Turkey. Journal of Medicinal Plants Research, 4, 1136–1140.
29.
SheldrickG.M. (2008) A short history of SHELX. Acta Crystallography, A64, 112–122.
30.
SermboonpaisarnT., SawasdeeP. (2012) Potent and selective butyrylcholinesterase inhibitors from Ficus foveolata. Fitoterapia, 83, 780–784.
